94 related articles for article (PubMed ID: 194513)
1. Discussion paper: dual effects of tumor antigens: induction of tumor resistance or tumor growth enhancement.
Nowotny A; Butler RC; Grohsman J; Keebler C
Ann N Y Acad Sci; 1976; 276():106-23. PubMed ID: 194513
[TBL] [Abstract][Full Text] [Related]
2. In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum.
Cooper AG; Codington JF; Brown MC
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1224-8. PubMed ID: 4524634
[TBL] [Abstract][Full Text] [Related]
3. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid.
Grohsman J; Nowotny A
J Immunol; 1972 Nov; 109(5):1090-5. PubMed ID: 4562425
[No Abstract] [Full Text] [Related]
4. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
[TBL] [Abstract][Full Text] [Related]
5. Differing electrical surface charge and transplantation properties of genetically variant sublines of the TA3 murine adenocarcinoma tumor.
Tenforde TS; Adesida PO; Kelly LS; Todd PW
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):277-82. PubMed ID: 6681773
[TBL] [Abstract][Full Text] [Related]
6. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
Biddison WE; Palmer JC
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
[TBL] [Abstract][Full Text] [Related]
7. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
Miller SC; Codington JF; Klein G
J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
[TBL] [Abstract][Full Text] [Related]
8. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.
Cooper AG; Codington JF; Miller DK; Brown MC
J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids.
Codington JF; Klein G; Cooper AG; Lee N; Brown MC; Jeanloz RW
J Natl Cancer Inst; 1978 Apr; 60(4):811-8. PubMed ID: 633390
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
[TBL] [Abstract][Full Text] [Related]
11. Suppressive factors in ascitic fluids and sera of mice bearing ascites tumors.
Elleman CJ; Eidinger D
J Natl Cancer Inst; 1977 Sep; 59(3):925-31. PubMed ID: 894749
[No Abstract] [Full Text] [Related]
12. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.
Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870
[TBL] [Abstract][Full Text] [Related]
13. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
14. Hybrid cells derived from fusion of TA3-Ha ascites carcinoma with normal fibroblasts. 1. Malignancy, karyotype, and formation of isoantigenic variants.
Klein G; Friberg S; Wiener F; Harris H
J Natl Cancer Inst; 1973 May; 50(5):1259-68. PubMed ID: 4712590
[No Abstract] [Full Text] [Related]
15. Studies on different stages in host-tumor relationship. 1. Differences in the behavior in vitro of ascites cells and lymphocytes derived from mice in early and later stages of tumor growth.
Pikovski MA
Isr J Med Sci; 1973 Feb; 9(2):136-44. PubMed ID: 4696151
[No Abstract] [Full Text] [Related]
16. Two kinds of antigen suppression in tumor cells revealed by cell fusion.
Klein G; Friberg S; Harris H
J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface macromolecular and morphological changes related to allotransplantability in the TA3 tumor.
Codington JF; Frim DM
Biomembranes; 1983; 11():207-58. PubMed ID: 6338947
[No Abstract] [Full Text] [Related]
18. Site dependency of TA3 Ha allotransplantability.
Hagmar B; Ryd W
Transplantation; 1977 Jan; 23(1):93-7. PubMed ID: 835167
[TBL] [Abstract][Full Text] [Related]
19. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
Rao VS; Bonavida B
Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
[TBL] [Abstract][Full Text] [Related]
20. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
Singhal A; Fohn M; Hakomori S
Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
